L&G Global Quality Dividends UCITS ETF Acc

The investment objective of the Fund is to provide exposure to companies with higher than average dividend and quality characteristics in developed market countries. The Fund will seek to track the performance of the FTSE Developed All Cap Dividend Growth with Quality Net Tax Index (the " Index "), subject to the deduction of the TER and other expenses. It will do so by investing primarily in an optimised portfolio of equity securities that, as far as possible and practicable, consists of the component securities of the Index in similar proportions to their weightings in the Index. Where consistent with its investment objective, the Fund may also invest in the following additional assets: companies that are not component securities of the Index, Depositary Receipts, Financial Derivative Instruments. The Fund may, in addition, employ other techniques relating to transferable securities, including entering into securities lending transactions, investing in repurchase and reverse repurchase transactions and money market collective investment schemes. The Fund promotes a range of environmental and social characteristics which are met by tracking the Index. Further information on how such characteristics are met by the Fund can be found in the Fund Supplement. The Index is designed to provide exposure to equity securities of companies in developed markets that have historically exhibited positive dividend growth trends, relatively higher forward estimated dividend yields, and better quality characteristics compared to other companies in developed markets. The Fund is considered to be passively managed as it aims to track the Index by using index 'sampling' techniques. Adjustments to the Fund's portfolio, including as a result of a reconstitution of the Index, will incur transaction costs. Shares in this share class (the " Shares ") are denominated in USD and can be bought and sold on stock exchanges by ordinary investors using an intermediary (e.g. a stockbroker). In n

Physical replication

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No